Ferrocene-Based Compounds with Antimalaria/Anticancer Activity

Malaria and cancer are chronic diseases. The challenge with drugs available for the treatment of these diseases is drug toxicity and resistance. Ferrocene is a potent organometallic which have been hybridized with other compounds resulting in compounds with enhanced biological activity such as antim...

Full description

Bibliographic Details
Main Authors: Sijongesonke Peter, Blessing Atim Aderibigbe
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/19/3604
_version_ 1819172940618399744
author Sijongesonke Peter
Blessing Atim Aderibigbe
author_facet Sijongesonke Peter
Blessing Atim Aderibigbe
author_sort Sijongesonke Peter
collection DOAJ
description Malaria and cancer are chronic diseases. The challenge with drugs available for the treatment of these diseases is drug toxicity and resistance. Ferrocene is a potent organometallic which have been hybridized with other compounds resulting in compounds with enhanced biological activity such as antimalarial and anticancer. Drugs such as ferroquine were developed from ferrocene and chloroquine. It was tested in the 1990s as an antimalarial and is still an effective antimalarial. Many researchers have reported ferrocene compounds as potent compounds useful as anticancer and antimalarial agents when hybridized with other pharmaceutical scaffolds. This review will be focused on compounds with ferrocene moieties that exhibit either an anticancer or antimalarial activity.
first_indexed 2024-12-22T20:15:10Z
format Article
id doaj.art-7a5420313db44be694dad8cdc17ed6a3
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-22T20:15:10Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-7a5420313db44be694dad8cdc17ed6a32022-12-21T18:13:58ZengMDPI AGMolecules1420-30492019-10-012419360410.3390/molecules24193604molecules24193604Ferrocene-Based Compounds with Antimalaria/Anticancer ActivitySijongesonke Peter0Blessing Atim Aderibigbe1Department of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South AfricaDepartment of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South AfricaMalaria and cancer are chronic diseases. The challenge with drugs available for the treatment of these diseases is drug toxicity and resistance. Ferrocene is a potent organometallic which have been hybridized with other compounds resulting in compounds with enhanced biological activity such as antimalarial and anticancer. Drugs such as ferroquine were developed from ferrocene and chloroquine. It was tested in the 1990s as an antimalarial and is still an effective antimalarial. Many researchers have reported ferrocene compounds as potent compounds useful as anticancer and antimalarial agents when hybridized with other pharmaceutical scaffolds. This review will be focused on compounds with ferrocene moieties that exhibit either an anticancer or antimalarial activity.https://www.mdpi.com/1420-3049/24/19/3604organometallicsmalariacancerferrocene compoundsferroquine
spellingShingle Sijongesonke Peter
Blessing Atim Aderibigbe
Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
Molecules
organometallics
malaria
cancer
ferrocene compounds
ferroquine
title Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
title_full Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
title_fullStr Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
title_full_unstemmed Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
title_short Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
title_sort ferrocene based compounds with antimalaria anticancer activity
topic organometallics
malaria
cancer
ferrocene compounds
ferroquine
url https://www.mdpi.com/1420-3049/24/19/3604
work_keys_str_mv AT sijongesonkepeter ferrocenebasedcompoundswithantimalariaanticanceractivity
AT blessingatimaderibigbe ferrocenebasedcompoundswithantimalariaanticanceractivity